Journals / Gülhane Tıp Dergisi / 2019 / Cilt: 61 - Sayı: 2

Reality of living with familial mediterranean fever identity”: A phenomenological study

Pages
33–40
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

This study shows what really matter for FMF patients and how they try to compete with long-term distress.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Aims:This phenomenological study was carried out to explore and describe FMF patients’ (n=15) life experiences and coping behaviors.
📊
Key Findings & Data:Results:Data analysis brought out three categories; (1) Living with an unnamed disease, (2) Living with FMF identity, (3) Coping with FMF symptoms.
💡
Conclusion & Impact:This study shows what really matter for FMF patients and how they try to compete with long-term distress.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Özet

Aims:This phenomenological study was carried out to explore and describe FMF patients’ (n=15) life experiences and coping behaviors. Methods:This study was conducted in the rheumatology outpatient clinic of a training and research hospital. Data was collected using both a demographic data form and a semi-structured interview form using in-depth, face-to-face interviews and analyzed by Colaizzi’s phenomenological data analysis method. Results:Data analysis brought out three categories; (1) Living with an unnamed disease, (2) Living with FMF identity, (3) Coping with FMF symptoms. Until being diagnosed with FMF, the patients have been had to live with the symptoms of an unnamed disease. After diagnosis, they try to adapt to FMF identity, which means unexpected recurrent attacks with physical effects, loss of social roles and functions, stigmatization and feelings of guilt. They try to continue their treatment and follow-up with the desire to maintain a healthy life and to cope with FMF. Conclusions:This study presents how patients experience living with an unnamed disease before being diagnosed, living with FMF identity and coping with FMF symptoms. Findings demonstrated that most of the troubles patients lived were related to the pain during the attacks and resultant limitations. This study shows what really matter for FMF patients and how they try to compete with long-term distress.

🔖

Cite This Article

YÜKSEL, Ç., ÇINAR, F. İ., ÇINAR, M., YILMAZ, S., TOSUN, N., PAY, S. (2019). Reality of living with familial mediterranean fever identity”: A phenomenological study. Gülhane Tıp Dergisi, Cilt: 61 - Sayı: 2, 33–40. https://ajindex.com/articles/225233

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Akar S, Soyturk M, Onen F, Tunca M. The relations between attacks and menstrual periods and pregnancies of familial Mediterranean fever patients. Rheumatol Int. 2006;26(7):676–679
  2. Ben-Chetrit E, Touitou I. Familial Mediterranean Fever in the world. Arthritis Rheum. 2009;61(10):1447–1453
  3. Atalay Y, Cakmak Ö, Asutay F, Ulu S, Eroğlu S, Solak O. Decreased mandibular bone mineral density in adults with familial Mediterranean fever. Acta Med Mediter. 2016;32:405–411
  4. Cebicci H, Cebicci AM, Sahan M, et al. Triggers for attacks in familial Mediterranean fever: are there any regionalor ethnic differences? Acta Med Mediterr 2014;30:1349-1353
  5. Karadag O, Tufan A, Yazisiz V, et al. The factors considered as trigger for the attacks in patients with familial Mediterranean fever. Rheumatol Int. 2013;33(4):893–897
  6. Makay B, Unsal E. Altered circadian rhythm: possible trigger of familial Mediterranean fever attacks. Med Hypotheses. 2009;73(4):630–631
  7. Onen F. Familial Mediterranean fever. Rheumatol Int. 2006;26(6):489–496
  8. Tunca M, Akar S, Onen F, et. al. Familial Mediterranean fever (FMF) in Turkey: results of a nationwide multicenter study. Medicine (Baltimore). 2005;84(1):1-11
  9. Polat A, Acikel C, Sozeri B, et al. FMF Arthritis Vasculitis and Orphan Disease Research in Pediatric Rheumatology (FAVOR). Comparison of the efficacy of once- and twice-daily colchicine dosage in pediatric patients with familial Mediterranean fever-a randomized controlled noninferiority trial. Arthritis Res Ther. 2016;18(1):85
  10. Arık F, Arık BE, Ozer O, Kalan U, Uyanıker N, Çetinkaya A. Fatal Intoxication with Colchicine. Acta Med Mediter. 2017;(33):593–596
  11. Sarı İ, Birlik M, Kasifoğlu T. Familial Mediterranean fever: an updated review. Eur J Rheumatol. 2014;1(1):21–33
  12. Cinar FI, Unver V, Yilmaz S, et al. Living with scleroderma: patients’ perspectives, a phenomenological study. Rheumatol Int. 2012;32(11):3573–3579
  13. Davies H, Brophy S, Dennis M, Cooksey R, Irvine E, Siebert S. Patient perspectives of managing fatigue in Ankylosing Spondylitis, and views on potential interventions: a qualitative study. BMC Musculoskelet Disord. 2013;14(14):163
  14. Bagcivan G, Cinar FI, Cinar M, Oflaz F, Uzun S, Pay S. Living with pain in ankylosing spondylitis: a qualitative study. Contemp Nurse. 2015;51(2-3):135–147
  15. Schwind JK, Fredericks S, Metersky K, Porzuczek VG. What can be learned from patient stories about living with the chronicity of heart illness? A nar